Affiliation:
1. Department of Chemistry, Middle East Technical University, Üniversiteler, Eskişehir Yolu No: 1, 06800 Çankaya/Ankara, Turkey
Abstract
Clofibrate is a lipid-lowering ester used for controlling the high cholesterol and triacylglyceride levels in the blood. In the present study, clofibrate isomers, their corresponding acids and carboxylate anions have been considered within the constraints of density functional theory at the level of B3LYP/6-31++G(d,p). Also, interactions of some of those species with the zinc(II) cation have been considered. Various quantum chemical data, including the UV-VIS spectra, have been collected and discussed. All the species considered possess favorable thermo chemical values and they are electronically stable. All the clofibrate isomers and the carboxylate anions of them strongly interact with the zinc cation affecting some properties of them.
Reference35 articles.
1. Oliver, M.F. (1963). Further observations on the effects of Atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels. J. Atheroscler. Res., 3(5-6), 427-444. https://doi.org/10.1016/S0368-1319(63)80023-X
2. Grundy, S.M., Ahrens, E.H., Salen, G., Schreibman, P.H., & Nestel, P.J. (1972). Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. Journal of Lipid Research, 13(4), 531-551. https://doi.org/10.1016/S0022-2275(20)39388-3
3. Mishkel, M.A. (1964). The treatment of xanthomatosis with Atromid. Med. J. Aust., 2(21), 828-833. https://doi.org/10.5694/j.1326-5377.1964.tb109734.x
4. Best, M.M., & Duncan, C.H. (1965). Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB). Amer. J. Cardiol., 15, 230-233. https://doi.org/10.1016/0002-9149(65)90459-5
5. Strisower, E.H., Nichols, A.V., Lindgren, F.T., & Smith, L. (1965). The effect of Sf 20-l05 concentration changes induced by ethyl chlorophenoxyisobutyrate on high-density lipoprotein lipid composition. J. Lab. Clin. Med., 65, 748-755. PMID: 14281371.